Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-20-000053

Director acquired 1,878 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Clancy Paul J · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2020-05-29 Exercise or conversion : show line 1 in the form +1,878 3,278 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2020-05-28 Grant or award : show line 2 in the form Stock options (right to buy) +8,096 8,096 D
2020-05-28 Grant or award : show line 3 in the form Restricted stock units +1,686 1,686 D
2020-05-29 Exercise or conversion : show line 4 in the form Restricted stock units −1,878 0 D
Loading xslF345X03/wf-form4_159104602309461.xml…